The Global Drugs for Vulvovaginal Candidiasis Market is witnessing steady growth, driven by increasing prevalence of vaginal yeast infections and rising awareness regarding women’s health. According to market insights, the market is projected to expand at a consistent pace during the forecast period from 2025 to 2031, supported by advancements in antifungal drug formulations and improved...